AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Next PLC

M&A Activity Oct 31, 2018

4824_rns_2018-10-31_76bcc8ea-0c4c-4a26-9313-750ef67543ee.html

M&A Activity

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8991F

FTSE

31 October 2018

CME Group (USA): Merger with NEX Group (UK)

Changes in FTSE UK Index Series

31 October 2018

Subject to court sanctioning the scheme of arrangement in relation to the cash and stock acquisition of NEX Group (UK, constituent) by CME Group (USA, non-constituent), please see details of affected indexes and effective dates below:

NEX Group (UK, BZ02MH1) will be deleted from the FTSE 250 Index.

Woodford Patient Capital Trust (UK, BVG1CF2) will be added to the FTSE 250 Index.

All changes effective from 02 November 2018.

Full Index change details are available on FTSE Russell website.

Please Note: The replacement company for the FTSE 250 Index was determined using 30 October 2018 close prices.

For further information please contact FTSE Russell Client Services at [email protected] or call:

Australia +1800 653 680
Hong Kong +852 2164 3333
Japan +81 3 4563 6346
London +44 (0) 20 7866 1810
New York +1866 551 0617

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2018 FTSE Russell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

FTSFDIFDFFASESS

Talk to a Data Expert

Have a question? We'll get back to you promptly.